Use of rituximab in the treatment of Epstein-Barr virus reactivation after allogeneic stem cell transplantation: a retrospective study in 86 patients

被引：0
|
作者：
Auger, S. [1 ]
Mines, M. L. [1 ]
Fegueux, N. [1 ]
Ceballos, P. [1 ]
Segondy, M. [1 ]
Rossi, J. -F. [1 ]
机构：
[1] St Eloi Univ Hosp, Montpellier, France
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S211 / S211
页数：1
相关论文
共 50 条
  • [31] Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus
    Seung Beom Han
    E Young Bae
    Jae Wook Lee
    Pil Sang Jang
    Dong-Gun Lee
    Nack-Gyun Chung
    Dae Chul Jeong
    Bin Cho
    Soon Ju Lee
    Jin Han Kang
    Hack-Ki Kim
    International Journal of Hematology, 2014, 100 : 188 - 199
  • [32] Epstein–Barr virus reactivation after allogeneic stem cell transplantation without lymph node enlargement
    William H. Krüger
    Frank Schüler
    Christian Lotze
    Günther Schwesinger
    Renate Mentel
    Christoph Busemann
    Gottfried Dölken
    Annals of Hematology, 2005, 84 : 477 - 478
  • [33] Features of Epstein-Barr virus reactivation after allogeneic hematopoietic cell transplantation in Korean children living in an area of high seroprevalence against Epstein-Barr virus
    Han, Seung Beom
    Bae, E. Young
    Lee, Jae Wook
    Jang, Pil Sang
    Lee, Dong-Gun
    Chung, Nack-Gyun
    Jeong, Dae Chul
    Cho, Bin
    Lee, Soon Ju
    Kang, Jin Han
    Kim, Hack-Ki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 100 (02) : 188 - 199
  • [34] EPSTEIN-BARR VIRUS INFECTION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: THE ROLE OF CYTOMEGALOVIRUS
    Liu, Q.
    Lin, R.
    Liu, C.
    Wu, M.
    Xuan, L.
    Jiang, X.
    Fan, Z.
    Zhang, Y.
    Huang, F.
    Zhou, H.
    Dai, M.
    Sun, J.
    HAEMATOLOGICA, 2014, 99 : 421 - 422
  • [35] A Co-Reactivation Model of Cytomegalovirus and Epstein-Barr Virus after Allogeneic Hematopoietic Stem Cell Transplantation Was Constructed to Predict Mortality after Transplantation
    Ren, Jinhua
    Chen, Shaozhen
    Hu, Jianda
    Yang, Ting
    BLOOD, 2023, 142
  • [36] Association of Epstein-Barr virus infection with allogeneic hematopoietic stem cell transplantation in patients in Portugal
    Marinho-Dias, Joana
    Baldaque, Ines
    Pinho-Vaz, Carlos
    Leite, Luis
    Branca, Rosa
    Campilho, Fernando
    Campos, Antonio, Jr.
    Medeiros, Rui
    Sousa, Hugo
    MOLECULAR MEDICINE REPORTS, 2019, 19 (03) : 1435 - 1442
  • [37] Pre-Emptive Rituximab Treatment for Epstein-Barr Virus (EBV) Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): High Incidence of Infections and Delayed Immune Reconstitution
    Petropoulou, Anna D.
    Porcher, Raphael
    de Latour, Regis Peffault
    Xhaard, Alienor
    Ribaud, Patricia
    Socie, Gerard
    Robin, Marie
    BLOOD, 2010, 116 (21) : 950 - 951
  • [38] Prospective Evaluation of Epstein-Barr Virus Reactivation After Stem Cell Transplantation: Association with Monoclonal Gammopathy
    Chiusolo, Patrizia
    Metafuni, Elisabetta
    Cattani, Paola
    Piccirillo, Nicola
    Santangelo, Rosaria
    Manzara, Stefania
    Bellesi, Silvia
    De Michele, Teresa
    Leone, Giuseppe
    Sica, Simona
    JOURNAL OF CLINICAL IMMUNOLOGY, 2010, 30 (06) : 894 - 902
  • [39] Incidence, risk factors, and clinical significance of Epstein-Barr virus reactivation in myelodysplastic syndrome after allogeneic haematopoietic stem cell transplantation
    Wang, Hong
    Zhang, Tong-Tong
    Qi, Jia-Qian
    Chu, Tian-Tian
    Miao, Miao
    Qiu, Hui-Ying
    Fu, Cheng-Cheng
    Tang, Xiao-Wen
    Ruan, Chang-Geng
    Wu, De-Pei
    Han, Yue
    ANNALS OF HEMATOLOGY, 2019, 98 (04) : 987 - 996
  • [40] Epstein-Barr virus reactivation in allogeneic stem cell transplantation: Relationship between viral load, EBV-specific T cell reconstitution and rituximab therapy
    Clave, E
    Agbalika, F
    Bajzik, V
    Socie, G
    Gluckman, E
    Charron, D
    Esperou, H
    Toubert, A
    Moins-Teisserenc, H
    GENES AND IMMUNITY, 2004, 5 : S5 - S5
12345